Previous close | 200.90 |
Open | 201.85 |
Bid | 0.00 x 1300 |
Ask | 321.44 x 800 |
Day's range | 201.56 - 208.02 |
52-week range | 180.54 - 254.00 |
Volume | |
Avg. volume | 486,025 |
Market cap | 20.355B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 36.20 |
EPS (TTM) | 5.69 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | 2.08 (1.01%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 239.86 |
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
STERIS (NYSE:STE) has had a rough month with its share price down 13%. We, however decided to study the company's...
Edwards Lifesciences, DexCom and STERIS have been highlighted in this Industry Outlook article.